As regulators push to phase out animal testing, Charles River’s Steve Bulera notes that widespread implementation of ...

Dynavax has revealed outcomes from the initial part of its Phase I/II trial, comparing its shingles vaccine Z-1018 against ...

This webinar offers essential tools and insights to help organisations confidently navigate the BioSecure Act, ensuring they ...

Tyra Biosciences has dosed the first paediatric participant in the dose-escalation/dose-expansion Phase II BEACH301 trial of ...

Padcev-Keytruda will now join Bristol Myers Squibb’s Opdivo in the list of bladder cancer drugs available on the NHS.

UK-based Monument Therapeutics has joined forces with the Foundation for the National Institutes of Health (FNIH), US, to ...

The upcoming Clinical Trials in Rare Diseases conference will cover the most concerning challenges in rare disease research.

The FDA has announced it will no longer accept clinical trials that involve sending US patients cells from US to China for ...

MTPA's oral therapy Radicava (edaravone) has shown decreased functional decline and improved survival in long-term ALS trials ...

Precision immunology company Scipher Medicine has introduced the ClinicalTrialRank.com AI platform to the public.

A501, which was placed on hold due to a patient death, will now resume with a reduced dose and altered regimen.

A recently published study provides an incentive to explore what specific aspects of vegetarianism are protective.